Studies on New Platelet Aggregation Inhibitors 1. Synthesis of 7-Nitro-3,4-dihydroquinoline-2(1H)-one Derivatives.
-
- IYOBE Akira
- Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
- UCHIDA Masahiko
- Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
- KAMATA Kouji
- Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
- HOTEI Yukihiko
- Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
- KUSAMA Hiroshi
- Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
- HARADA Hiromu
- Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
この論文をさがす
抄録
A series of 6-cyclic aliphatic amino-7-nitro-3, 4-dihydroquinoline-2(1H)-ones were prepared and tested for platelet aggregation inhibitory effect, cardiotonic activity and chronotropic activity. These compounds appeared to show selective inhibitory activity against platelet aggregation. Among them, 6-(4-ethoxycarbonylpiperidino)-7-nitro-3, 4-dihydroquinoline-2(1H)-one (22f) showed the most potent inhibitory activity and high selectivity. A divergent synthetic route to 6-cyclic aliphatic amino-7-nitro-3, 4-dihydroquinoline-2(1H)-one derivatives has also been investigated.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 49 (7), 822-829, 2001
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679140536704
-
- NII論文ID
- 110003616000
-
- NII書誌ID
- AA00602100
-
- COI
- 1:CAS:528:DC%2BD3MXkvVartLw%3D
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 5820257
-
- PubMed
- 11456086
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可